On November 5, 2018 Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms, reported that third quarter 2018 financial results will be released on Thursday, November 8, 2018 before the market opens (Press release, Cambrex, NOV 5, 2018, View Source [SID1234530775]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company will host a conference call to discuss the financial results.

Third Quarter 2018 Earnings Conference Call
When: Thursday, November 8, 2018 at 8:30 a.m. Eastern Time
Dial-in: 1-877-830-2649 for U.S.
+1-785-424-1824 for International
Passcode: 3109072
Dial-in Replay: 1-888-203-1112 for U.S.
+1-719-457-0820 for International
Passcode: 3109072
Available through Thursday, November 15, 2018
Webcast: www.cambrex.com